Jeffrey S. Heier, M.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jeffrey S. Heier, M.D.
Jeffrey S. Heier, M.D. is recorded as Board Member at Ocular Therapeutix, Inc (OCUL). Ocular Therapeutix, Inc reported in an 8-K filed June 16, 2023 that Jeffrey S. Heier, M.D. was appointed Class III director, effective June 14, 2023.
“The Company's stockholders elected Jeffrey S. Heier, M.D. and Merilee Raines as Class III directors to serve until the 2026 Annual Meeting of Stockholders, each such director to hold office until his or her successor has been duly elected and qualified.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Ocular Therapeutix, Inc (OCUL)
SEC 8-K
Current2024-02-21–present
-
Current
2023-06-14–present
-
2023-06-16–2024-02-21
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Ocular Therapeutix, Inc
Other people whose current roles at this company are on record from its filings.
- Pravin Dugel CEO
- Pravin U. Dugel CEO, Chairman, Board Member
- Pravin U. Dugel, M.D. CEO, Chairman
- Charles Warden Chairman, Board Member
- Jason Robins CFO
- Donald Notman COO
- Philip C. Strassburger General Counsel
- Adrienne L. Graves Board Member
- Adrienne L. Graves, Ph.D. Board Member
- Jeffrey Heier Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.